Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kamil

Showing results (61-70 of 11,761) with videos related to

Pageof 1,177
Sort By:
Ceska a Slovenska Farmacie : Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti|August 24, 2012
[Gamma-secretase inhibitors in Alzheimer's disease therapy]Spilovská Katarína, Korábečný Jan, Kuča Kamil, et al.
Foods (Basel, Switzerland)|February 13, 2025
Lipids in Clinical Nutrition and Health: Narrative Review and Dietary RecommendationsAdrian Frydrych, Kamil Kulita, Kamil Jurowski, et al.
The British Journal of Oral & Maxillofacial Surgery|August 26, 2006
A comparison of midazolam and midazolam with remifentanil for patient-controlled sedation during operations on third molarsHasan Garip, Yavuz Gürkan, Kamil Toker, et al.
Neurotoxicity Research|April 24, 2007
In vitro reactivation potency of acetylcholinesterase reactivators--K074 and K075--to reactivate tabun-inhibited human brain cholinesterasesKamil Kuca, Jiri Cabal, Daniel Jun, et al.
Neurotoxicity Research|December 10, 2015
Small Quaternary Inhibitors K298 and K524: Cholinesterases Inhibition, Absorption, Brain Distribution, and ToxicityJana Zdarova Karasova, Milos Hroch, Kamil Musilek, et al.
Toxicology Mechanisms and Methods|September 26, 2009
A comparison of reactivating and therapeutic efficacy of newly-developed oximes (K156, K203) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and miceJiri Kassa, Jana Zdarova Karasova, Kamil Musilek, et al.
Annals of Medicine and Surgery (2012)|December 11, 2025
Reaffirming the role of iodine in cognitive health: a call for lifespan-based public health actionZehra Sadia, Tooba Khurshid, Musawer Khan, et al.
Drug and Chemical Toxicology|May 1, 2010
A comparison of the reactivating and therapeutic efficacy of newly developed oximes (K347, K628) with commonly used oximes (obidoxime, HI-6) against tabun in rats and miceJiri Kassa, Jana Zdarova Karasova, Kamil Kuca, et al.
Neurotoxicity Research|May 16, 2012
Time-dependent changes of oxime K027 concentrations in different parts of rat central nervous systemJana Zdarova Karasova, Filip Zemek, Kamil Musilek, et al.
Medicinal Research Reviews|December 23, 2009
Design, evaluation and structure-activity relationship studies of the AChE reactivators against organophosphorus pesticidesKamil Musilek, Martin Dolezal, Frank Gunn-Moore, et al.
Pageof 1,177

Showing results (61-70 of 11,761) with videos related to

Sort By:
Pageof 1,177
Ceska a Slovenska Farmacie : Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti|August 24, 2012
[Gamma-secretase inhibitors in Alzheimer's disease therapy]Spilovská Katarína, Korábečný Jan, Kuča Kamil, et al.
Foods (Basel, Switzerland)|February 13, 2025
Lipids in Clinical Nutrition and Health: Narrative Review and Dietary RecommendationsAdrian Frydrych, Kamil Kulita, Kamil Jurowski, et al.
The British Journal of Oral & Maxillofacial Surgery|August 26, 2006
A comparison of midazolam and midazolam with remifentanil for patient-controlled sedation during operations on third molarsHasan Garip, Yavuz Gürkan, Kamil Toker, et al.
Neurotoxicity Research|April 24, 2007
In vitro reactivation potency of acetylcholinesterase reactivators--K074 and K075--to reactivate tabun-inhibited human brain cholinesterasesKamil Kuca, Jiri Cabal, Daniel Jun, et al.
Neurotoxicity Research|December 10, 2015
Small Quaternary Inhibitors K298 and K524: Cholinesterases Inhibition, Absorption, Brain Distribution, and ToxicityJana Zdarova Karasova, Milos Hroch, Kamil Musilek, et al.
Toxicology Mechanisms and Methods|September 26, 2009
A comparison of reactivating and therapeutic efficacy of newly-developed oximes (K156, K203) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and miceJiri Kassa, Jana Zdarova Karasova, Kamil Musilek, et al.
Annals of Medicine and Surgery (2012)|December 11, 2025
Reaffirming the role of iodine in cognitive health: a call for lifespan-based public health actionZehra Sadia, Tooba Khurshid, Musawer Khan, et al.
Drug and Chemical Toxicology|May 1, 2010
A comparison of the reactivating and therapeutic efficacy of newly developed oximes (K347, K628) with commonly used oximes (obidoxime, HI-6) against tabun in rats and miceJiri Kassa, Jana Zdarova Karasova, Kamil Kuca, et al.
Neurotoxicity Research|May 16, 2012
Time-dependent changes of oxime K027 concentrations in different parts of rat central nervous systemJana Zdarova Karasova, Filip Zemek, Kamil Musilek, et al.
Medicinal Research Reviews|December 23, 2009
Design, evaluation and structure-activity relationship studies of the AChE reactivators against organophosphorus pesticidesKamil Musilek, Martin Dolezal, Frank Gunn-Moore, et al.
Pageof 1,177